Relationship between branched-chain amino acid to tyrosine ration (BTR) and porto-systemic shunt in the child-pugh grade A cirrhosis determined by per-rectal portal scintigraphy

Hepatology Research

Volumn 27, Issue 1, 2003, Pages 57-61

  Habu, Daiki ^a   Nishiguchi, Shuhei ^a   Nakatani, Shinji ^a   Kawamura, Etsushi ^a   Ishizu, Hirotaka ^a   Lee, Chulyoo ^a   Ohfuji, Satoko ^a   Fukushima, Wakaba ^a   Tanaka, Takashi ^a   Kawamura, Toji ^a   Shiomi, Susumu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Branched chain amino acid to tyrosine ratio; Cirrhosis; Per rectal portal scintigraphy; Technetium 99m

Indexed keywords

ALBUMIN; BRANCHED CHAIN AMINO ACID; PERTECHNETIC ACID TC 99M; TYROSINE;

ADULT; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DETERIORATION; DIGESTIVE TRACT PARAMETERS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER SCINTISCANNING; MALE; PORTAL VEIN BLOOD FLOW; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RECTUM; STATISTICAL ANALYSIS;

EID: 0141828596     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(03)00191-8     Document Type: Article

References (13)

1. Yoshida T, Muto Y, Moriwaki H, Yamato MI. Effect of long-term effect of oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Gastroenterol Japonica 1989;24:692-8.
2. Yamauchi M, Takeda K, Sakamoto K, Ohata M, Toda G. Effect of oral branched-chain amino acid supplementation in the late evening on the nutritional state of patients with live cirrhosis. Hepatol Res 2001;21:199-204.
3. Habu D, Nishiguchi S, Nakatani N, et al. Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot study, Hepatol. Res., in press.
4. Azuma Y, Maekawa M, Kuwabara Y, et al. Determination of branched-chain amino acids and tyrosine in serum of patients with various hepatic diseases, and its clinical usefulness. Clin Chem 1989;35:1399-403.
5. Campallo O, Sprengers D, McIntyre N. The BCAA/AAA ratio of plasma amino acid in three different groups of cirrhotics. Rev Invest Clin 1992;44:513-8.
6. Kawamura YN, Kaito M, Nakagawa N, et al. Evaluating response to nutritional therapy using the branched-chain amino acid tyrosine ratio in patients with chronic liver disease. J Clin Lab Anal 1999;13:31-4.
7. Shiomi S, Kuroki T, Kurai O, et al. Portal circulation by technetium-99m pertechnetate per-rectal portal scintigraphy. J Nucl Med 1998;29:460-5.
8. Shiomi S, Kuroki T, Ueda T, et al. Clinical usefulness of evaluation of portal circulation by per-rectal portal scintigraphy with technetium-99m pertechnetate. Am J Gastroenterol 1995;90:460-5.
9. Habu D, Nishiguchi S, Enomoto M, et al. Ultrasonographic diagnosis of degree of chronic type-C liver disease, Hepatogastroenterology, in press.
10. O'Keefe SJD, Abraham R, EL-Zayadi A, Marshall W, Davis M, Williams R. Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and related hepatic oxidation capacity. Gastroenterology 1981;81:1017-24.
11. Ferenci P, Wealka F. Plasma amino acids in hepatic encephalopathy. J Neural Transm Suppl 1978;14:87-94.
12. Faull KF, Gan I, Halpern B, et al. Metabolic studies on two patients with non-hepatic tyrosinemia using deuterated tyrosine loads. Pediatr Res 1977;11:631-7.
13. Vilstrup H, Bucher D, Krog B, Damgard SE. Elimination of infused amino acids from plasma of control subjects and of patients with cirrhosis of the liver. Eur J Clin Invest 1982;12:197-202.